Patient preferences for pancreatic cancer treatment (PERSEUS): a multicenter discrete choice experiment.

ABSTRACT:

Background

Pancreatic cancer has an aggressive nature, and treatment severely impacts patients' quality of life. There is limited understanding how patients weigh treatment benefits against side effects, which hampers the development of patient-centered care and shared decision-making programs.

Methods

Two discrete-choice surveys were designed: one comprising pancreatic cancer patients with (borderline) resectable disease (early-stage disease), and one including patients with non-resectable or metastatic disease (late-stage disease). Relevant criteria for describing treatments were identified by literature review and validated through patient and expert interviews. Selected criteria were likelihood of adverse events causing hospitalization, impact on daily functioning, gastr

SUBMITTER: Lansbergen MF 

PROVIDER: S-EPMC12729412 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature